A new class of broadly neutralizing antibodies that target the glycan loop of Zika virus envelope protein
by Qu et al.Results showed in this article have strong implications for developing anti-ZIKV vaccines and therapeutic mAbs.
4th February 2020 •
comment
Viral emergence and immune interplay in flavivirus vaccines
by Fischer et al.Comment
1st January 2020 •
comment
Yeast-produced subunit protein vaccine elicits broadly neutralizing antibodies that protect mice against Zika virus lethal infection
by Zhang et al.Yeast-derived EDIII is a safe and effective ZIKV vaccine candidate with desirable production traits.
1st October 2019 •
comment
A yellow fever–Zika chimeric virus vaccine candidate protects against Zika infection and congenital malformations in mice
by Kum et al.The authors of this study report the engineering of a chimeric virus vaccine candidate (YF-ZIKprM/E) by replacing the antigenic surface glycoproteins and the capsid anchor of YFV-17D with those of a prototypic Asian lineage ZIKV isolate.
13th December 2018 •
comment
4 EU-funded Zika consortia met in Marseille during the International Symposium to discuss a common strategy for vaccine development
by ZIKAlliance
14th June 2018 •
comment